Exosome-derived ncRNAs and proteins: inflammation regulatory mechanisms and biomarker potential in spinal cord injury
Wang Y., Zhang J., Liu J., Li Y., Zhao X., Yang Z.
Narrative Review on Spinal Cord Injury, Neuroinflammation, Scar, Chronic Inflammation, published in Front Mol Biosci (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Front Mol Biosci (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41988222
- PMCID
- PMC13076182
- DOI
- 10.3389/fmolb.2026.1787949
Abstract (original English)
Objective Exosomes, as key intercellular communication carriers, can deliver non-coding RNAs (ncRNAs) and proteins to regulate inflammatory networks, but the molecular mechanisms underlying their regulation of macrophage polarization in Spinal cord injury (SCI) remain to be systematically elucidated. This review is to interpret the molecular mechanism of exosomal ncRNA/protein regulating macrophage polarization and inflammatory network in SCI-associated neuroinflammation, and summarize its potential as a therapeutic target. Methods We screened PubMed and Embase databases from January 2010 to January 2026 to search for published studies. The search keywords used are as follows: ["exosome cargo" or "exosome"], [ncRNA"], ["spinal cord injury" or "SCI"], ["immune regulation"], ["inflammatory reaction"], ["neuroregeneration" or "nerve"]. 151 peer-reviewed studies on human/animal models were included, and articles that did not meet the requirements were excluded. Results Exosomes drive SCI pathology via multi-layered molecular networks: Pro-inflammatory exosomal miR-155-5p activates NF-κB/NLRP3 by inhibiting FoxO3a, promoting M1 macrophage polarization and TNF-α/IL-1β/IL-6 release, exacerbating neuronal pyroptosis. Anti-inflammatory exosomal ncRNAs exert synergistic effects: miR-146a targets TLR4/MyD88, miR-340-5p suppresses JAK2/STAT3, and miR-16-5p is sponged by circZFHX3 to upregu
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Host immune determinants of stromal vascular fraction graft survival: Toward a concept of SVF therapy resistance - A systematic narrative review.
Systematic Review on Spinal Cord Injury, Chronic Inflammation, Immune Modulation, published in Cell Transplant (2026) — summary generated from the PubMed abstract.
- 2026
Cell Transplant - Level AMeta-analysisPubMed
Stem cell-derived exosome treatment for acute spinal cord injury: a systematic review and meta-analysis based on preclinical evidence.
Meta-analysis on Spinal Cord Injury, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurol - Level ASystematic ReviewPubMed
Brain-derived neurotrophic factor (BDNF) as biomarker in stem cell-based therapies of preclinical spinal cord injury models: A systematic review.
Systematic Review on Spinal Cord Injury, published in Tissue Cell (2025) — summary generated from the PubMed abstract.
- 2025
Tissue Cell3 citations - Level ASystematic ReviewEurope PMC
Revolutionizing neural regeneration with smart responsive materials: Current insights and future prospects
Systematic Review on Spinal Cord Injury, published in Bioact Mater (2025) — summary generated from the PubMed abstract.
- 2025
Bioact Mater5 citations - Level ASystematic ReviewEurope PMC
Conductive Nanocomposite Hydrogels for Neural Tissue Engineering: A Systematic Scoping Review of Recent Trends
Systematic Review with a reported sample of 42 on Diabetic Foot, Stroke Research, Spinal Cord Injury, Neuroinflammation, published in Adv Sci (Weinh) (2025) — summary generated from the PubMed abstract.
- 2025
- n = 42
Adv Sci (Weinh)18 citations - Level ASystematic ReviewEurope PMC
Emerging regenerative strategies for spinal cord injury: exosome-derived mechanisms and therapeutic insights
Systematic Review on Spinal Cord Injury, Neuroinflammation, published in Front Neurosci (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurosci